IndiaDescription
Pure-play manufacturer of active pharmaceutical ingredients, headquartered with its plant in Vadodara and operating since 2006. States 88 APIs, 69 drug master files — 36 of them US filings — 20 European certificates of suitability and around 100 products. Focus on cardiovascular, antidiabetics, central nervous system and respiratory, with acebrophylline, dapagliflozin, tranexamic acid and vildagliptin. Supplies more than 60 countries.